SLU PP 333: PROPRIETARY ANALOGUE OF SLU PP 332

SLU PP 333 is our proprietary Estrogen Related Receptor Agonist, developed as an analogue to SLU PP 332, a compound widely recognized and often referred to as the “exercise in a pill.”

Our molecule is almost exactly the same as the SLU PP 332, comes from the same research paper and is superimposable, bioidentical, with all of the same activity, if not greater.

We are proud to announce that we are now producing this groundbreaking Estrogen Related Receptor Agonist, originally known as SLU PP 332, under our exclusive brand name SLU PP 333. The ingredient is manufactured at our FDA-registered facility in Fort Lauderdale and then encapsulated at a separate FDA facility in Hialeah using our proprietary, patent-pending blend with Nicotinamide.

Each capsule delivers 10,000 micrograms of active ingredient, combined with Nicotinamide for enhanced mitochondrial stimulation.

How It Works  

SLU-PP-333 activates estrogen related receptors (ERRα, ERRβ, and ERRγ), mimicking the metabolic effects of endurance exercise.

Key Benefits  

• Increases energy expenditure  

• Boosts fat metabolism without appetite suppression  

• Improves mitochondrial function  

• Enhances glucose tolerance & insulin sensitivity  

• Supports weight loss without muscle degradation  

• Potential kidney-protective benefits (per preclinical studies)

Research Backing  

SLU-PP-333 has demonstrated endurance increases of up to 70%, reduced fat gain, and 12% body weight loss in obese mice, even with no change in activity or diet.